Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Search results (73)

« Back to Publications

Robotising vitreoretinal surgeries.

Mi H. et al, (2025), Eye (Lond), 39, 673 - 682

XOLARIS: A 24-Month, Prospective, Natural History Study of 201 Participants with Retinitis Pigmentosa GTPase Regulator-Associated X-Linked Retinitis Pigmentosa

MacLaren RE. et al, (2025), Ophthalmology Science, 5, 100595 - 100595

Real-world six-month outcomes in patients switched to faricimab following partial response to anti-VEGF therapy for neovascular age-related macular degeneration and diabetic macular oedema.

Borchert GA. et al, (2024), Eye (Lond), 38, 3569 - 3577

Expanding the genotypic and phenotypic spectra with a novel variant in the ciliopathy gene, CFAP410, associated with selective cone degeneration.

Borchert GA. et al, (2024), Ophthalmic Genet, 45, 633 - 639

A novel frameshift variant in LAMP2 gene mimicking choroideremia carrier retinopathy

Narayan A. et al, (2024), Ophthalmic Genetics, 45, 668 - 675

Establishing Clinical Trial Endpoints in Selecting Patients for RPGR Retinal Gene Therapy

Christou EE. et al, (2024), Translational Vision Science & Technology, 13, 18 - 18

Multimodal Evaluation and Management of Wagner Syndrome—Three Patients from an Affected Family

Szeligowski T. et al, (2024), Genes, 15, 1178 - 1178

Assessment of Visual Function with Cotoretigene Toliparvovec in X-Linked Retinitis Pigmentosa in the Randomized XIRIUS Phase 2/3 Study

Lam BL. et al, (2024), Ophthalmology, 131, 1083 - 1093

Retinal Focal Nodular Gliosis (Vasoproliferative Tumors) Have Varied Clinical Courses Requiring Tailored Management: A Case Series.

Ie A. et al, (2024), Ocul Oncol Pathol, 10, 175 - 181

Genetic therapies and potential therapeutic applications of CRISPR activators in the eye.

Ng BW. et al, (2024), Prog Retin Eye Res, 102

Robot-Assisted Eye Surgery: A Systematic Review of Effectiveness, Safety, and Practicality in Clinical Settings.

Thirunavukarasu AJ. et al, (2024), Transl Vis Sci Technol, 13

In Silico CRISPR-Cas-Mediated Base Editing Strategies for Early-Onset, Severe Cone-Rod Retinal Degeneration in Three Crumbs homolog 1 Patients, including the Novel Variant c.2833G>A.

Shamsnajafabadi H. et al, (2024), Genes (Basel), 15

Age-related macular degeneration: suitability of optogenetic therapy for geographic atrophy.

Borchert GA. et al, (2024), Front Neurosci, 18

Is RPGR-related retinal dystrophy associated with systemic disease? A case series

Han RC. et al, (2023), Ophthalmic Genetics, 44, 577 - 584

Outcomes and Adverse Effects of Voretigene Neparvovec Treatment for Biallelic RPE65-Mediated Inherited Retinal Dystrophies in a Cohort of Patients from a Single Center

Kiraly P. et al, (2023), Biomolecules, 13, 1484 - 1484

Load More

1
2
3
4
5